Unlock Clinically Proven Results with Dual-Action Precision
Tirzepatide is a groundbreaking dual GLP-1 and GIP receptor agonist, offering unparalleled benefits in weight management, glycemic control, and cardiovascular health. Each pack contains 10 vials of Tirzepatide, providing a research-grade solution for advanced metabolic studies. Backed by FDA approval for obesity and type 2 diabetes, this peptide delivers transformative results, including up to 23.6 kg (52 lbs) of weight loss over 72 weeks in clinical trials, making it a premier choice for scientists and clinicians.